PMPN_Pharmaceutical & Medical Packaging News

Pharmaceutical & Medical Packaging News, November/December 2015

Issue link: http://dc.cn.ubm-us.com/i/609216

Contents of this Issue

Navigation

Page 12 of 35

13 November/December 2015 Pharmaceutical & Medical Packaging News • pmpnews.com advanced diagnostics to patients and doctors and we are pleased to play a very small part in their supply chain process." Nexus Dx packages its devices in unit-of-use foil pouches and packs them 10 to a carton. Robinson Print- ing provides the boxes and multiple- language IFU booklets. For the boxes, Baker was looking for a solution that would help save labor during assem- bly. "I wanted an autoclose bottom, which automatically closes with little efort," says Baker. The boxes are designed so that "when you square up the sides, the bottom forms automatically, easing the assembly process," explains Lori Robinson, marketing coordinator for Robinson Printing. Made from a sturdy 24-pt box- board, the boxes "provide significant product protection without having to go with a corrugated stock," she says. The IFU is a relatively thick booklet, ranging from 80 to 108 pages, with six diferent languages. With so many pag- es required for the multiple languages, Robinson Printing suggested a very thin, 30# paper stock to Nexus Dx. "With the thinner paper, we've been able to reduce the overall weight and thickness of the booklet. It is common for us to use 40#, 30#, and even a very thin 27# paper for our customers' IFU booklets, map-folds, and mini- folds. With significant content, these lighter weights allow for much more information and ensure less impact on the product it accompanies," she adds. At the customer's request, Robinson Printing will often provide samples of an IFU on varied paper thicknesses to show the difference a thinner paper can make in weight and volume, the company reports. Because Nexus Dx stores its prod- ucts under refrigeration, a few years ago the company noticed some rust developing on the booklets' staples. Robinson Printing consulted its pro- duction and regulation team, and they suggested testing and validating a gal- vanized wire for stitching and stapling. This material passed all the internal moisture tests. "We suggested the change to Nexus Dx as a solution," she says. "Now it is standard for all our booklet wiring." The two companies are now plan- ning for growth. "We plan to grow, quickly," Baker says. "We will ramp up in the future, and Robinson says it is ready to go whenever we are." —Daphne Allen Robinson Printing produces IFU booklets and boxes for Nexus Dx. Imagine the Possibilities When Medtech and Pharma Converge T he best and the brightest in the medtech industry are asking why there are still boundaries between drug and medical device development," observes Anthony Kalaijakis, strate- gic marketing manager, medical, for Molex, LLC. He sees a diferent busi- ness approach emerging today. Molex has been known for its design of electronics and interconnect devices supporting diagnostic, therapeutic, and patient-monitoring applications. A few years ago the company started getting inquiries about drug-delivery systems, reports Kalaijakis. Already increasing its capabilities through a number of acquisi- tions, Molex added ProTek Medical to its portfolio earlier this year given its exper- tise in developing drug-delivery systems. "We've had a wide base of customers in device development, and we've tradi- tionally served the hardware or electron- ics side, also known as the distal end," says Kalaijakis. "We were looking to fill in some of the blanks in terms of drug delivery, so that's what led us to ProTek. There are specific requirements to meet, so we needed its knowledge base for com- pliance and safety." The acquisition was timely for both companies, given the convergence of medtech and pharma witnessed by Eamon O'Connell, ProTek's direc- tor of business development. "I see a convergence as the pharmaceutical industry seeks to deliver drugs in high- er concentration to specific areas. Site- specific treatments are less demanding and achieve a desirable pharmaco- logical response at the selected site, but with a site-specific delivery, you need a device. It requires capabilities from the device market. ProTek has developed the capability to support a Pharma company with the plastics design and manufacturing combined with a regu- latory strategy that support the new drug application." When asked for examples of such innovations, O'Connell described a proj- ect in which a generic drug company sought to develop an alternative to a cop- per coil traditionally used for contracep- tion. "The customer approached us to design a plastic implant for a slow-releas- ing drug product. ProTek provided the necessary device design inputs and came up with a delivery device for a 5-year release of drug." Given Molex's experience in electron- ics, it can help ProTek with such research. And Kalaijakis expects "more and more magical transitions" as medtech and pharma continue to converge. "It will be interesting to see what would develop if the barriers between these industries were to break down," he says. Kalaijakis adds that Molex can help with the design continuum, han- dling industrial design, development of sophisticated tooling, qualification, manufacturing, and packaging.

Articles in this issue

Links on this page

Archives of this issue

view archives of PMPN_Pharmaceutical & Medical Packaging News - Pharmaceutical & Medical Packaging News, November/December 2015